Company press release

June 10, 2026 Artifactsofresearch, Inc. Donates Business to Not-for-Profit Foundation to Advance Global Fight Against Substandard and Falsified Medicines

Artifactsofresearch, Inc., a C-corporation founded in 2017, today announced the completion of a transformative transaction donating 100% of the company and its shares to a U.S.-based 501(c)(3) non-profit organization dedicated to combating substandard and falsified pharmaceuticals (SF) worldwide.

The BoKoMo Foundation, founded by Dr Marya Lieberman by the Nancy Dee Professor of Cancer Research at the University of Notre Dame, has been created to further pioneering research and advance low-cost chemical screening technologies designed to detect SF drugs.

This donation places Artifactsofresearch’s flagship technology, Artifacts VERIFY, under the stewardship of The BoKoMo Foundation to ensure continued development, deployment, and broad accessibility of Artifacts VERIFY for public health impact.

The BoKoMo Foundation will deploy Artifacts VERIFY alongside Portable Analytical Device (PAD) testing tools to support providers, researchers, and regulators. BoKoMo’s operating model emphasizes accessibility through affordable sliding-scale pricing, open scientific collaboration, and global data sharing to strengthen pharmaceutical quality monitoring systems.

Artifacts VERIFY is a comprehensive post-market surveillance system designed to identify and report substandard and falsified (SF) drugs across the pharmaceutical supply chain. Combining rapid field-testing using Paper Analytical Devices (PADs), AI-powered mobile diagnostics, laboratory confirmation, and blockchain-secured data analytics, the system enables real-time detection, reporting, and mitigation of unsafe medicines.

“Over the past several years, our collaboration with Dr. Marya Lieberman and her research collaborators has demonstrated the power of combining scientific rigor with scalable technology to address one of the most urgent challenges in global health,” said David Kochalko, CEO and co-founder of Artifactsofresearch, Inc. “By placing Artifacts VERIFY within The BoKoMo Foundation, we are ensuring this capability is guided by a mission-driven organization committed to expanding access, advancing research, and protecting the health and safety of patients worldwide.”

Substandard and falsified medicines represent a significant and underrecognized global health threat. Studies have shown that approximately one in ten pharmaceuticals in low- and middle-income countries fail to meet quality standards, contributing to ineffective treatment, antimicrobial resistance, and preventable mortality.

Dr. Lieberman oversees a global network of academic laboratories and collaborators. Through BoKoMo, these efforts will expand to reach broader communities, particularly in regions where access to quality medicines remains a critical challenge. For Artifacts VERIFY the donation is designed to maximize the potential of the system to:

• Expand access to drug quality screening tools worldwide
• Enable real-time, data-driven responses to SF medicines
• Support scientific research and regulatory oversight
• Protect patients and improve health outcomes

The company’s leadership team—David Kochalko, George Moore, and Michael Boswood—expressed confidence that this transition will accelerate global efforts to detect and eliminate unsafe medicines from the supply chain. The donation of the business and its technology to BoKoMo will enable the foundation to license this essential technology in support its charitable mission.

“This is about putting powerful tools into the hands of the people best equipped to use them—scientists, clinicians, and public health professionals—and ensuring that the benefits reach patients everywhere.”

Artifactsofresearch, Inc. will operate as a subsidiary of BoKoMo and will license its technology to the foundation free of charge to support its charitable mission.